Clinical Trial Update: Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function [Phase 1]

View source ↗

Summary

A completed Phase 1 trial assessed temsirolimus in patients with metastatic solid tumors or lymphoma who have varying levels of liver function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hepatic Complications, Lymphoma | Phase 1 | Status: COMPLETED